Abstract
The influence of tautomerism on the precise structure of drugs and thus of their potential to interact with biological systems is discussed from thermodynamic and kinetic aspects. The types of tautomerism encountered in the structure of drugs in current use are surveyed together with the effect of pH, solvent polarity, and temperature.
Similar content being viewed by others
Notes
The indistinct line between slowly inter-converting tautomers and structural isomers is generally considered to fall somewhere in between CH/CH tautomerism (ΔG≠ ≈ 25–35 kcal mol−1) and cis/trans isomers (ΔG≠ ≥ 60 kcal mol−1 since the average energy for cleavage of a π bond is 63 kcal mol−1).
References
Katritzky AR, Lagowski JM (1963) Adv Heterocycl Chem (Katritzky AR (eds) Academic Press, New York, N.Y.) 1: 311–338
Katritzky AR, Lagowski JM (1963a) Adv Heterocycl Chem (Katritzky AR (eds) Academic Press, New York) 1: 339–437
Katritzky AR, Lagowski JM (1963b) Adv Heterocycl Chem (Katritzky AR (eds) Academic Press, New York) 2: 1–26
Elguero J, Marzin C, Katritzky A, Linda P (1976) Adv Heterocycl Chem, Supplement 1: the tautomerism of heterocycles. Academic Press, New York
Katritzky AR (1970) Chimia 24:134–146
Gronowitz S, Hoffman RA (1960) Arkiv foer Kemi 15:499–512
Hino T, Nakagawa M, Hashizume T, Yamaji N, Miwa Y, Tsuneoka K, Akaboshi S (1971) Tetrahedron 27:775–787
Dickinson RP, Iddon B (1970) J Chem Soc C 14:1926–1928
Woerner FP, Reimlinger H, Merenyi R (1971) Chem Ber 104:2789–2792
Katritzky AR, Jozwiak A, Lue P, Yannakopoulou K, Palenik GJ, Zhang ZY (1990) Tetrahedron 46:633–640
Katritzky AR, El-Gendy B-EM, Draghici B, Hall CD, Steel PJ (2010) Manuscript in preparation
Cox BG (1994) Modern liquid phase kinetics. Oxford University Press, New York
Hore PJ (1995) Nuclear magnetic resonance. Oxford University Press, New York
Shanan-Atidi H, Bar-Eli KH (1970) J Phys Chem 74:961–963
McKeage K, Blick SKA, Croxtall JD, Lyseng-Williamson KA, Keating GM (2008) Drugs 68:1571–1607
Inoue M, Zhai H, Sakazaki H, Furuyama H, Fukuyama Y, Hirama M (2004) Bioorg Med Chem 14:663–665
Cheer SM, Prakash A, Faulds D, Lamb M (2003) Drugs 63:101–132
Th Moenius VR, Burtscher P, Zuger Ch (2000) J Labelled Compd Radiopharm 43:1245–1252
Becker A (2008) PCT Int Appl WO 2008149155A1
Alkorta I, Rozas I, Elguero J (1998) J Chem Soc Perkin Trans 2:2671–2675
Mulvany MJ, Skov K, Eiskjær H, Hansen HE, Madsen JK, Kvist S, Mulvany MJ (2007) Hypertension 50:89–95
Wilson TW, Lacourciere Y, Barnes CC (1998) CMAJ 159:469–476
Bauer M, Harris RK, Rao RC, Apperley DC, Rodger CA (1998) J Chem Soc, Perkin Trans 2:475–482
Myznikov LV, Hrabalek A, Koldobskiil GI (2007) Chem Heterocycl Comp 43:1–9
McCarthy KE, Wang Q, Tsai EW, Gilbert RE, Dominic P, Brooks MA (1998) J Pharm Biomed Anal 17:671–677
Cagigal E, Gonzalez L, Alonso RM, Jimenez RM (2001) J Pharm Biomed Anal 26:477–486
Fudemberg SJ, Batiste C, Katz LJ (2008) Expert Opin Drug Saf 7:795–799
JackmanIb LM, Jen T (1975) J Am Chem Soc 97:2811–2818
Varga LI, Ako-Agugua N, Colasante J, Hertweck L, Houser T, Smith J, Watty AA, Naga S, Raffa RB (2009) J Clin Pharm Ther 34:493–505
Pool CR, Roman RS, Brighwell MD, Tremper AW (1994) PCT Int Appl WO9405659A1
Seufert J (2006) Curr Med Res Opin 22:S39–S48
Poklis JL, Ropero-Miller JD, Garside D, Winecker RE (2004) J Anal Toxicol 28:537–540
Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD (2004) Expert Rev Neurotherapeutics 4:33–41
Daluge SM, Good SS, Faleto MB, Miller WH, St. Clair MH, Boone LR, Tisdale M, Parry NR, Reardon JE, Dornsife RE, Averett DR, Krenitsky TA (1997) Antimicrob Agents Chemother 41:1082–1093
Daluge SM (1991) U.S. Patent US5034394A
Deeks SG, Barditch-Crovo P, Lietman PS, Hwang F, Cundy KC, Rooney JF, Hellmann NS, Safrin S, Kahn JO (1998) Antimicrob Agents Chemother 42:2380–2384
Binnie CD, Boas WVE, Land W, Meijer GS, Overweg JWA, Van Wieringen A (1985) Br J Clin Pharmacol 20: 285 (abstract)
Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML (1999) J Am Acad Dermatol 41:1002–1007
Sidky YA, Borden EC, Weeks CE, Reiter MJ, Hatcher JF, Bryan GT (1992) Cancer Res 52:3528–3533
Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Hoda S, Mclntosh J, Kurie J, Dmitrovsky E (1993) Cancer Res 53:2379–2385
Grandis JR, Tweardy DJ (1993) Cancer Res 53:3579–3584
Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, Diorio C, Doty J, Morin MJ, Moyer MP, Neveu M, Pollack VA, Pustilnik LR, Reynolds MM, Sloan D, Theleman A, Miller P (1997) Cancer Res 57:4838–4848
Bartlett JB, Dredge K, Dalgleish AG (2004) Nat Rev Cancer 4:314–322
Laffitte E, Revuz J (2004) Expert Opin Drug Saf 3:47–56
Murphy RL, Brun S, Hicks C, Eron JJ, Gulick R, King M, White AC, Benson C, Thompson M, Kessler HA, Hammer S, Bertz R, Hsu A, Japour A, Sun E (2001) AIDS 15:F1–F9
Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foa R, Corso A, Masliak Z, Marta Olesnyckyj, Yu Z, Patin J, Zeldis JB, Knight RD (2007) N Engl J Med 357:2123–2132
Weber D, Chen C, Niesvizky R, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD (2007) N Engl J Med 357:2133–2142
Young SD, Britcher SF, Tran LO, Payne LS, Lumma WC, Lyle TA, Huff JR, Anderson PS, Olsen DB, Carroll SS, Pettibone DJ, O’Brien JA, Ball RG, Balani SK, Lin JH, Chen I-WU, Schleif WA, Sardana VV, Long WJ, Byrnes VW, Emini EA (1995) Antimicrob Agents Chemother 39:2602–3605
Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW (2002) J Clin Psychiatry 63:763–771
Thomas LN, Douglas RC, Lazier CB, Too CKL, Rittmaster RS, Tindall DJ (2008) Eur Urol 53:244–252
Miller J, Tarter TH (2009) Clin Interv Aging 4:251–258
Gormley GJ, Stoner E, Rittmaster RS, Gregg H, Thompson DL, Lasseter KC, Vlasses PH, Steven EA (1990) J Clin Endocrinol Metab 70:1136–1141
Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ (1995) Antimicrob Agents Chemother 39:1546–1553
DeJesus E, Wald A, Warren T, Schacker TW, Trottier S, Shahmanesh M, Hill JL, Brennan CA (2003) J Infect Dis 188:1009–1016
Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ (1977) Proc Natl Acad Sci USA 74:5716–5720
Schaeffer HJ, Beauchamp L, de Miranda P, Elion GB, Bauer DJ, Collins P (1978) Nature 272:583–585
McGavin JK, Goa KL (2001) Drugs 61:1153–1183
Singh N (2000) Clin Liver Dis 4:657–673
Van der Bij W, Speich R (2001) Clin Infect Dis 33(Suppl 1):S32–S37
Schinazi RF, McMillan A, Cannon D, Mathis R, Lloyd RM, Peck A, Sommadoss JP, St Clair M, Wilson J, Furman PA, Painter GR, Choi WB, Liotta DC (1992) Antimicrob Agents Chemother 36:2423–2431
Furman PA, Davis M, Liotta DC, Paff M, Frick LW, Nelson DJ, Dornsife RE, Wurster JA, Wilson LJ, Fyfe JA, Tuttle JV, Miller WH, Condreay L, Averett DR, Schinazi RF, Painter GR (1992) Antimicrob Agents Chemother 36:2686–2692
Tisdale M, Kemp SD, Parry NR, Larder BA (1993) Proc Natl Acad Sci USA 90:5653–5656
Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Debt JC, Barber J, Stephenson SL, Gray DF (1998) N Engl J Med 339:61–68
Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HWL, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA (1999) N Engl J Med 341:1256–1263
Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin R, Hawley S, Gray DF et al (1998) Hepatology 28(Suppl):43
Ishitsuka H, Miwa M, Ishikawa T, Ura M, Sawada N, Nishida M, Fukase Y, Yamamoto T, Mori K, Arasaki M, Umeda I, Shimma N (1995) Proc Am Assoc Cancer Res 36:407
Terrett NK, Bell AS, Brown D, Ellis P (1996) Bioorg Med Chem Lett 6:1819–1824
Turker L (2000) ACH-Models Chem 137:767–774
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katritzky, A.R., Hall, C.D., El-Gendy, B.ED.M. et al. Tautomerism in drug discovery. J Comput Aided Mol Des 24, 475–484 (2010). https://doi.org/10.1007/s10822-010-9359-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-010-9359-z